Skip to main content
All Recalls

Every New England Compounding Center Recall

Sorted by most recent. Click any recall for full details.

19 recalls
High RiskFDA
New England Compounding Center
All Sterile Products manufactured by NECC (New England Compounding Center), Framingham, MA. A complete list of products can be found on ...
Drugs·0 affected·Oct 6, 2012
High RiskFDA
New England Compounding Center
All Non Sterile Products manufactured by NECC (New England Compounding Center), Framingham, MA. A complete list of products can be found...
Drugs·0 affected·Oct 6, 2012
CriticalFDA
New England Compounding Center
Methylprednisolone Acetate (PF) 40 mg/ml Injection, supplied in 1 mL, 2 mL and 5 mL vials, manufactured by New England Compounding Center...
Injectable Drugs·9,062 affected·Sep 26, 2012
High RiskFDA
New England Compounding Center
Glycerin 100% PF, 1mL, 2 mL, and 5 mL vials, manufactured by New England Compounding Center, Framingham, MA
Drugs·165 affected·Sep 26, 2012
CriticalFDA
New England Compounding Center
Methylprednisolone Acetate 40 mg/mL Injection, Preserved, supplied in 5 mL and 10 mL vials, manufactured by New England Compounding Cent...
Injectable Drugs·5,130 affected·Sep 26, 2012
High RiskFDA
New England Compounding Center
Isovue 200 mg/mL PF and 300 mg/mL PF, Vials, manufactured by New England Compounding Center, Framingham, MA
Drugs·7,055 affected·Sep 26, 2012
High RiskFDA
New England Compounding Center
Omnipaque 240mg/mL PF, 300mg/mL PF, in 3 mL, 5 mL, and 10 mL, vials, manufactured by New England Compounding Center, Framingham, MA
Drugs·8,919 affected·Sep 26, 2012
High RiskFDA
New England Compounding Center
Saline 10% and 3%, in 5 mL and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA
Drugs·54 affected·Sep 26, 2012
High RiskFDA
New England Compounding Center
Triamcinolone 10 mg/mL P, 40mg/mL P, 40mg/mL PF and 80 mg/mL PF in 1 mL, 2 mL, 5 mL, and 10 mL vials, manufactured by New England Compou...
Drugs·56,655 affected·Sep 26, 2012
High RiskFDA
New England Compounding Center
Lidocaine 1% PF, 2% PF, and 4% PF, in 1 mL, 2 mL, 5 mL, and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA
Drugs·3,321 affected·Sep 26, 2012
High RiskFDA
New England Compounding Center
Betamethasone Repository 6 mg/mL PF Injection and Betamethasone Repository 6 mg/mL P Injection, manufactured by New England Compounding C...
Injectable Drugs·0 affected·Sep 26, 2012
High RiskFDA
New England Compounding Center
Betamethasone Sodium Phosphate 6 mg/mL P Injection, Betamethasone Sodium Phosphate 6 mg/mL PF Injection, Betamethasone Sodium Phosphate...
Injectable Drugs·0 affected·Sep 26, 2012
High RiskFDA
New England Compounding Center
Bupivacaine 0.25% PF, Bupivacaine 0.5% PF, and Bupivacaine 0.75% PF, manufactured by New England Compounding Center, Framingham, MA
Drugs·0 affected·Sep 26, 2012
CriticalFDA
New England Compounding Center
Methylprednisolone Acetate (PF) 80 mg/ml Injection, supplied in 1 mL, 2 mL and 5 mL vials, manufactured by New England Compounding Center...
Injectable Drugs·23,897 affected·Sep 26, 2012
High RiskFDA
New England Compounding Center
Clonidine 100 mcg/mL PF, 1mL and 2 mL vials, manufactured by New England Compounding Center, Framingham, MA
Drugs·2,747 affected·Sep 26, 2012
High RiskFDA
New England Compounding Center
Lidocaine/Dextrose 5%/7.5% PF, manufactured by New England Compounding Center, Framingham, MA
Drugs·0 affected·Sep 26, 2012
CriticalFDA
New England Compounding Center
Methylprednisolone Acetate 80 mg/mL Injection, Preserved, supplied in 5 mL and 10 mL vials, manufactured by New England Compounding Cent...
Injectable Drugs·3,822 affected·Sep 26, 2012
High RiskFDA
New England Compounding Center
Dexamethasone Sodium Phosphate 4 mg/mL vials PF, 6 mg/mL PF vials, and 8 mg/mL PF vials, manufactured by New England Compounding Center, ...
Drugs·20 affected·Sep 26, 2012
High RiskFDA
New England Compounding Center
Hyaluronidase 150 u/ml PF, 1 mL, 5 mL, and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA
Drugs·10,865 affected·Sep 26, 2012